Publications
13
Citations
345
Est. group size
—
Recurring co-author estimate
Active years
34
Publishing since 1992
Clover Caldwell works in medicine, with published work touching on cancer treatment and outcomes, including biomarker analysis in gastric and gastroesophageal junction cancer treated with a targeted antibody therapy. The available record also lists broader medical topics such as cognitive impairment, liver cancer, and cancer survivorship, though these carry low relevance scores.
Publication activity is limited, with no recorded output through 2023 followed by a small cluster of publications in 2024 and 2025, averaging about 1.2 per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
British Journal of Cancer · 2016
- Innovation in Aging×2
- British Journal of Cancer×1
- Journal of Medical Internet Research×1
- JMIR Aging×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile